Difference between revisions of "Pediatric Lomustine Dosing Chart"
Jump to navigation
Jump to search
| Line 13: | Line 13: | ||
! style="width: 25%" |Body Surface Area (m<sup>2</sup>) | ! style="width: 25%" |Body Surface Area (m<sup>2</sup>) | ||
! style="width: 25%" |Ideal Dose (75 mg/m<sup>2</sup>/day once daily) | ! style="width: 25%" |Ideal Dose (75 mg/m<sup>2</sup>/day once daily) | ||
| − | ! style="width: 25%" |Actual Dose to be Given | + | ! style="width: 25%" |Actual Dose to be Given |
|- | |- | ||
|2.0 | |2.0 | ||
Revision as of 22:10, 2 December 2021
Section editor transclusions This page contains studies that were specific to pediatric populations. For the more general AML page, follow this link.
0 regimens on this page
0 variants on this page
|
ACNS0331 Lomustine Dosing Nomogram
| Body Surface Area (m2) | Ideal Dose (75 mg/m2/day once daily) | Actual Dose to be Given |
|---|---|---|
| 2.0 | 150 mg, | 150 mg |
| 1.9 | 143 | 140 |
| 1.8 | 135 | 130 |
| 1.7 | 128 | 130 |
| 1.6 | 120 | 120 |
| 1.5 | 112 | 110 |
| 1.4 | 105 | 100 |
| 1.3 | 98 | 100 |
| 1.2 | 90 | 90 |
| 1.1 | 82 | 80 |
| 1.0 | 75 | 80 |
| 0.95 | 71 | 70 |
| 0.9 | 68 | 70 |
| 0.85 | 64 | 60 |
| 0.8 | 60 | 60 |
| 0.75 | 56 | 60 |
| 0.7 | 53 | 50 |
| 0.65 | 49 | 50 |
| 0.6 | 45 | 40 |
| 0.55 | 41 | 40 |
| 0.5 | 38 | 40 |
| 0.45 | 34 | 30 |
| 0.4 | 30 | 30 |
| 0.35 | 26 | 30 |
| 0.3 | 23 | 20 |